GlassScriptPhysician profile
Eric A Tallarico
NPI 1811929086
$7,742.93
in general payments reported to CMS, 2019-2025
20 companies · $2,056 in 2025
The $2,056 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $524 · 2021: $314 · 2022: $751 · 2023: $1,071 · 2024: $2,008 · 2025: $2,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,134.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,907.97 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Prestige LP Cervical Disc System |
| Boston Scientific Corporation | $1,532.09 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Medtronic USA, INC. | $759.12 | 2019-2020 | |
| Saluda Medical Americas, INC. | $640.27 | 2024-2025 | Evoke |
| Curonix LLC | $592.61 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $564.84 | 2019-2025 | Eterna, Proclaim |
| Vertos Medical, INC. | $470.74 | 2019-2024 | Mild Device Kit |
| Relievant Medsystems, INC. | $292.38 | 2022-2023 | Intracept |
| Stryker Corporation | $225.50 | 2024-2025 | Mild Device Kit |
| Nevro Corp. | $199.09 | 2020-2024 | Senza |
| Spr Therapeutics, INC | $136.15 | 2023-2024 | Sprint Pns System |
| Nalu Medical, INC. | $118.19 | 2021-2024 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $68.17 | 2022-2024 | Xtampza |
| Biohaven Pharmaceutical Holding Company LTD. | $61.30 | 2022 | |
| Vertiflex, INC. | $41.84 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $37.61 | 2025 | Reactiv8 |
| Scilex Pharmaceuticals INC. | $30.19 | 2019-2024 | |
| Pfizer INC. | $27.80 | 2023 | |
| Xeris Pharmaceuticals, INC. | $20.61 | 2023 | Keveyis |
| Ibsa Pharma INC. | $16.46 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Tallarico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.